Please enter the email address you used to register, then we will send you a link to choose a new password
Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient E...
- Reuters
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $7 pri...
Microbot Medical Inc. (NASDAQ:MBOT) today announced that it has entered into definitive agreements for the purchase and sale of...
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with...
The study will be conducted in the U.S., and the Company has already signed a clinical trial service agreement with a leading a...
-SEC Filing
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price ...
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in...